NEW YORK, Oct. 24 - Invitrogen today said that moderate third-quarter revenue growth atop steep cuts in operating expenses helped the company reach profitability.
Registering provides access to this and other free content.
Already have an account?Login Now.
A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.
Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.
In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.
A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.